ArticlePharmaceutical research2022

Transcriptome Profiling Analysis Identifies LCP1 as a Contributor for Chidamide Resistance in Gastric Cancer.

Wenfang Bao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.